XIX FIGO WORLD CONGRESS OF GYNECOLOGY AND OBSTETRICS INDUSTRY-SPONSORED SYMPOSIA Monday, 5 October 2009 13h00-14h15 Ballroom East (CTICC) Contraception and Beyond: Evidence-based Indications for LNG-IUS 1. Wider Use of Intrauterine Contraception - David Grimes
2. The LNG-IUS in Heavy Menstrual Bleeding: First-line Treatment Based on Comprehensive Clinical Data - Anita Nelson
3. Safety and Efficacy of Consecutive Use of the LNG-IUS - Confirmed by a New Study -Kristina Gemzell-Danielsson
Symposium sponsored by Bayer Schering Pharma Ballroom West (CTICC) The Role of GARDASIL™ in Reducing the Global Burden of Cervical Cancer and Other HPV-Related Diseases 1. Opening Remarks – Lynette Denny, South Africa
2. Global HPV Epidemiology and Burden of Disease - Lynette Denny, South Africa3. Gardasil Efficacy and Recent Clinical Data - Suzanne M. Garland, Australia
4. MSD’s Commitment: Access to Gardasil in the Developing World - Carlos Sattler, USA
Symposium sponsored by MSD Tuesday, 6 October 2009 13h00-14h15 Ballroom East (CTICC) Innovation in Contraception 1. Ethinylestradiol 20mcg/Drospirenone 3mg Administered in a 24/4 Regimen: A New OC Goes Beyond Contraception - Joachim Marr and Lorraine Dennerstein
2. A New OC Concept with Additional Benefit - Wolfgang Holzgreve and Klaus Pietrzik
Symposium sponsored by Bayer Schering Pharma Ballroom West (CTICC) Overactive Bladder: TIME to take notice Chairman’s Introduction
1. The Burden and Implications of OAB – Linda Cardozo, UK2. Initial Diagnosis and Assessment of Women with LUTS - Mickey Karram, USA3. Making Sure We Understand Our Patient’s Needs – Peter de Jong, South Africa
4. Ensuring Successful Management with Pharmacotherapy - Willy Davilla, USA
Symposium sponsored by Astellas Pharma Wednesday, 7 October 2009 13h00-14h15 Ballroom East (CTICC) Evolution of a Revolution: Introducing a New Class of Oral Contraceptive
1. Introducing E2V/DNG - Ian Fraser2. E2V/DNG: Contraceptive Efficacy and Safety Data - Jeffrey T. Jensen
3. First Experience with the Estradiol Based Combined Oral Contraceptive E2V/DNG - Diana Mansour
Symposium sponsored by Bayer Schering Pharma Ballroom West (CTICC) Effective Solutions for Enhanced Obstetric Management 1. New Ultrasound Technologies in Assisted Reproductive Medicine SonoAVC - Nick Raine Fenning, Nottingham, UK
2. Enhancing the Monitoring Experience from Antepartum through to Postpartum - Philippe Barjot, Caen, France
3. Improving Obstetric Workflow, Archiving and Reporting - Philippe Barjot, Caen, France
Symposium sponsored by GE Healthcare Thursday, 8 October 2009 13h00-14h15 Ballroom East (CTICC) Improving Women's Healthcare - a Contemporary View Chair: Jennifer Blake 1. Progestins - An Important Versatile Class – Peter Rogers
2. Specialised Progestins I - Dienogest in Endometriosis - Alfred Mueck3. Specialised Progestins II – Drospirenone in Menopause - Tommaso Simoncini
Symposium sponsored by Bayer Schering Pharma Ballroom West (CTICC) Cervarix®: Focusing on the Global Needs of Cervical Cancer Vaccination 1. Welcome and Introduction – Anne Szarewski, UK and Hugues Bogaerts, Belgium
2. The Relevance of the HPV Type Distribution in Cervical Cancer – F. Xavier Bosch, Spain3. Understanding the Immunological Potential of HPV Vaccines – Peter L. Stern, UK4. Cervarix®: The Benefits to Girls and Women: From Clinical Trials to Clinical Practice – Anne
Symposium sponsored by GlaxoSmithKline
Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors Learning Objectives After reading and reviewing this material, the participant should be better able to:• Identify symptoms of androgen deficiency in pre and post menopausal breast cancer survivors• Recognize the potential role of subcutaneous testosterone-anastrozole implant therapy in safely tr